Haemonetics Corporation Deferred Revenue Recognized
Haemonetics Corporation (HAE) reported Deferred Revenue Recognized of $15.80 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-06
- Haemonetics Corporation contract with customer, liability, revenue recognized for the quarter ending 2026-06-27 was $15.80M, a 18.80% increase year-over-year.
- Haemonetics Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-12-27 was $6.00M, a 22.45% increase year-over-year.
- Haemonetics Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-09-27 was $9.90M, a 16.47% increase year-over-year.
- Haemonetics Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-06-28 was $13.30M, a 0.00% change year-over-year.
- Haemonetics Corporation contract with customer, liability, revenue recognized for fiscal 2026 was $5.40M, a 81.44% decline from fiscal 2025.
- Haemonetics Corporation contract with customer, liability, revenue recognized for fiscal 2025 was $29.10M, a 4.30% increase from fiscal 2024.
- Haemonetics Corporation contract with customer, liability, revenue recognized for fiscal 2024 was $27.90M, a 14.81% increase from fiscal 2023.
- Haemonetics Corporation contract with customer, liability, revenue recognized for fiscal 2023 was $24.30M, a 27.89% increase from fiscal 2022.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-27 | $15.80M 10-Q · filed 2026-08-06 | |||
| 2026-03-28 | $5.40M 10-K · filed 2026-05-20 | |||
| 2025-12-27 | $6.00M 10-Q · filed 2026-02-05 | $30.90M 10-Q · filed 2026-02-05 | ||
| 2025-09-27 | $9.90M 10-Q · filed 2025-11-06 | $24.90M 10-Q · filed 2025-11-06 | ||
| 2025-06-28 | $13.30M 10-Q · filed 2025-08-07 | |||
| 2025-03-29 | $29.10M 10-K · filed 2025-05-21 | |||
| 2024-12-28 | $4.90M 10-Q · filed 2025-02-06 | $26.70M 10-Q · filed 2025-02-06 | ||
| 2024-09-28 | $8.50M 10-Q · filed 2024-11-07 | $21.80M 10-Q · filed 2024-11-07 | ||
| 2024-06-29 | $13.30M 10-Q · filed 2024-08-08 | |||
| 2024-03-30 | $27.90M 10-K · filed 2024-05-20 | |||
| 2023-12-30 | $4.90M 10-Q · filed 2024-02-08 | $25.40M 10-Q · filed 2024-02-08 | ||
| 2023-09-30 | $7.00M 10-Q · filed 2023-11-02 | $20.50M 10-Q · filed 2023-11-02 | ||
| 2023-07-01 | $13.50M 10-Q · filed 2023-08-08 | |||
| 2023-04-01 | $24.30M 10-K · filed 2023-05-22 | |||
| 2022-12-31 | $3.90M 10-Q · filed 2023-02-07 | |||
| 2022-10-01 | $6.80M 10-Q · filed 2022-11-08 | |||
| 2022-07-02 | $11.70M 10-Q · filed 2022-08-10 | |||
| 2022-04-02 | $19.00M 10-K · filed 2022-05-25 | |||
| 2022-01-01 | $4.00M 10-Q · filed 2022-02-08 | $17.20M 10-Q · filed 2022-02-08 | ||
| 2021-10-02 | $4.60M 10-Q · filed 2021-11-09 | $13.20M 10-Q · filed 2021-11-09 | ||
| 2021-07-03 | $8.60M 10-Q · filed 2021-08-11 | |||
| 2021-04-03 | $17.10M 10-K · filed 2021-05-26 | |||
| 2020-12-26 | $2.50M 10-Q · filed 2021-02-02 | $16.30M 10-Q · filed 2021-02-02 | ||
| 2020-09-26 | $4.80M 10-Q · filed 2020-11-04 | $13.70M 10-Q · filed 2020-11-04 | ||
| 2020-06-27 | $8.90M 10-Q · filed 2020-08-04 | |||
| 2020-03-28 | $17.70M 10-K · filed 2020-05-20 | |||
| 2019-12-28 | $3.10M 10-Q · filed 2020-02-04 | $16.50M 10-Q · filed 2020-02-04 | ||
| 2019-09-28 | $5.00M 10-Q · filed 2019-11-01 | $13.40M 10-Q · filed 2019-11-01 | ||
| 2019-06-29 | $8.50M 10-Q · filed 2019-08-06 | |||
| 2019-03-30 | $15.00M 10-K · filed 2019-05-22 | |||
| 2018-12-29 | $2.90M 10-Q · filed 2019-02-05 | $14.40M 10-Q · filed 2019-02-05 | ||
| 2018-09-29 | $4.10M 10-Q · filed 2018-11-06 | $11.50M 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $7.40M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |